CAJ | 학술논문

全视网膜激光光凝(PRP)和黄斑激光光凝(MPC)是增生型糖尿病视网膜病变(DR)和糖尿病黄斑水肿治疗的金标准.随着激光设备普及和技术发展,眼底病激光治疗已逐步普及,但存在治疗标准不一致,疗效不理想的问题.原因固然是多方面的,但不能施行规范的PRP和MPC以及对激光治疗的适应证掌握不准确是其主要因素.正确掌握激光治疗适应证,合理应用激光光凝技术,关注激光治疗与药物治疗的联合应用,加强激光治疗技术的规范性,将有助于提高激光治疔的疗效.
전시망막격광광응(PRP)화황반격광광응(MPC)시증생형당뇨병시망막병변(DR)화당뇨병황반수종치료적금표준.수착격광설비보급화기술발전,안저병격광치료이축보보급,단존재치료표준불일치,료효불이상적문제.원인고연시다방면적,단불능시행규범적PRP화MPC이급대격광치료적괄응증장악불준학시기주요인소.정학장악격광치료괄응증,합리응용격광광응기술,관주격광치료여약물치료적연합응용,가강격광치료기술적규범성,장유조우제고격광치정적료효.
Pan-retinal photocoagulation (PRP) and macular photocoagulation (MPC) are the gold standard treatments for proliferative diabetic retinopathy (DR) and diabetic macular edema. With the development of equipment and technology advancement, photocoagulation has been gradually applied in many Eye Centers all over China. However, there are still several problems such as no standardized guideline and undesirable therapeutic effects. In this article we will summarize the indications and techniques of photocoagulation, and when and how to apply drug treatments for retinal diseases; aim at improving the criterion and clinical effects of photocoagulation.